Background: The fractional exhaled nitric oxide (FeNO) test is a point-of-care test that is
used in the assessment of asthma. Objective: To provide evidence-based clinical guidance …

The aim of this review was to evaluate the clinical effectiveness of fractional exhaled nitric
oxide (F eNO) measured in a clinical setting for the management of asthma in adults. 13 …

Asthma is a common and heterogeneous disease characterized by lower airway
inflammation and airflow limitation. Critical factors in asthma management include …

Background: Measurement of fractional nitric oxide (NO) concentration in exhaled breath
(FeNO) is a quantitative, noninvasive, simple, and safe method of measuring airway …

Rationale: Current asthma guidelines recommend adjusting antiinflammatory treatment on
the basis of the results of lung function tests and symptom assessment, neither of which are …

Asthma is a chronic inflammatory disease of the airways, affecting over 350 million people
worldwide and placing a significant burden on healthcare providers and wider society …

Background Current asthma guidelines recommend treatment based on the assessment of
asthma control using symptoms and lung function. Noninvasive markers are an attractive …

BACKGROUND: Asthma is an inflammatory disease, yet clinical tools that evaluate asthma
control do not include measures of inflammation. OBJECTIVE: To determine the correlation …

Background Asthma guidelines aim to guide health practitioners to optimise treatment for
patients so as to minimise symptoms, improve or maintain good lung function, and prevent …

The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management - Abstract
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …